![Rolf HESSELMANN | Radiopharmaceuticals Senior Expert (Clinical Studies, Market Authorisations, Special Approvals) | Dr. sc. ETH | Bundesamt für Gesundheit, Schweiz, Bern | BAG | Strahlenschutz Sektion Forschung & Nuklearmedizin | Research profile Rolf HESSELMANN | Radiopharmaceuticals Senior Expert (Clinical Studies, Market Authorisations, Special Approvals) | Dr. sc. ETH | Bundesamt für Gesundheit, Schweiz, Bern | BAG | Strahlenschutz Sektion Forschung & Nuklearmedizin | Research profile](https://www.researchgate.net/profile/Rolf-Hesselmann/publication/49654817/figure/fig1/AS:394359485812737@1471034036027/year-old-female-patient-92-months-postoperatively-with-the-lowest-of-three-cervical_Q320.jpg)
Rolf HESSELMANN | Radiopharmaceuticals Senior Expert (Clinical Studies, Market Authorisations, Special Approvals) | Dr. sc. ETH | Bundesamt für Gesundheit, Schweiz, Bern | BAG | Strahlenschutz Sektion Forschung & Nuklearmedizin | Research profile
Strahlenschutz und Überwachung der Radioaktivität in der Schweiz Ergebnisse 2015 Radioprotection et surveillance de la radioa
![Rolf HESSELMANN | Radiopharmaceuticals Senior Expert (Clinical Studies, Market Authorisations, Special Approvals) | Dr. sc. ETH | Bundesamt für Gesundheit, Schweiz, Bern | BAG | Strahlenschutz Sektion Forschung & Nuklearmedizin | Research profile Rolf HESSELMANN | Radiopharmaceuticals Senior Expert (Clinical Studies, Market Authorisations, Special Approvals) | Dr. sc. ETH | Bundesamt für Gesundheit, Schweiz, Bern | BAG | Strahlenschutz Sektion Forschung & Nuklearmedizin | Research profile](https://www.researchgate.net/profile/Rolf-Hesselmann/publication/49654817/figure/tbl1/AS:394359485812747@1471034036882/F-fluoride-uptake-around-cages-in-20-patients-with-30-cervical-and-or-lumbar_Q320.jpg)
Rolf HESSELMANN | Radiopharmaceuticals Senior Expert (Clinical Studies, Market Authorisations, Special Approvals) | Dr. sc. ETH | Bundesamt für Gesundheit, Schweiz, Bern | BAG | Strahlenschutz Sektion Forschung & Nuklearmedizin | Research profile
![Rolf HESSELMANN | Radiopharmaceuticals Senior Expert (Clinical Studies, Market Authorisations, Special Approvals) | Dr. sc. ETH | Bundesamt für Gesundheit, Schweiz, Bern | BAG | Strahlenschutz Sektion Forschung & Nuklearmedizin | Research profile Rolf HESSELMANN | Radiopharmaceuticals Senior Expert (Clinical Studies, Market Authorisations, Special Approvals) | Dr. sc. ETH | Bundesamt für Gesundheit, Schweiz, Bern | BAG | Strahlenschutz Sektion Forschung & Nuklearmedizin | Research profile](https://www.researchgate.net/profile/Rolf-Hesselmann/publication/49654817/figure/fig4/AS:394359485812742@1471034036529/year-old-female-patient-102-and-35-months-postoperatively-with-no-increased-uptake_Q320.jpg)
Rolf HESSELMANN | Radiopharmaceuticals Senior Expert (Clinical Studies, Market Authorisations, Special Approvals) | Dr. sc. ETH | Bundesamt für Gesundheit, Schweiz, Bern | BAG | Strahlenschutz Sektion Forschung & Nuklearmedizin | Research profile
![An Embedded Fragment Method for Molecules in Strong Magnetic Fields | Journal of Chemical Theory and Computation An Embedded Fragment Method for Molecules in Strong Magnetic Fields | Journal of Chemical Theory and Computation](https://pubs.acs.org/cms/10.1021/acs.jctc.2c00865/asset/images/large/ct2c00865_0005.jpeg)
An Embedded Fragment Method for Molecules in Strong Magnetic Fields | Journal of Chemical Theory and Computation
![Rolf HESSELMANN | Radiopharmaceuticals Senior Expert (Clinical Studies, Market Authorisations, Special Approvals) | Dr. sc. ETH | Bundesamt für Gesundheit, Schweiz, Bern | BAG | Strahlenschutz Sektion Forschung & Nuklearmedizin | Research profile Rolf HESSELMANN | Radiopharmaceuticals Senior Expert (Clinical Studies, Market Authorisations, Special Approvals) | Dr. sc. ETH | Bundesamt für Gesundheit, Schweiz, Bern | BAG | Strahlenschutz Sektion Forschung & Nuklearmedizin | Research profile](https://i1.rgstatic.net/ii/profile.image/436271425298433-1481026621239_Q512/Rolf-Hesselmann.jpg)
Rolf HESSELMANN | Radiopharmaceuticals Senior Expert (Clinical Studies, Market Authorisations, Special Approvals) | Dr. sc. ETH | Bundesamt für Gesundheit, Schweiz, Bern | BAG | Strahlenschutz Sektion Forschung & Nuklearmedizin | Research profile
![Rolf HESSELMANN | Radiopharmaceuticals Senior Expert (Clinical Studies, Market Authorisations, Special Approvals) | Dr. sc. ETH | Bundesamt für Gesundheit, Schweiz, Bern | BAG | Strahlenschutz Sektion Forschung & Nuklearmedizin | Research profile Rolf HESSELMANN | Radiopharmaceuticals Senior Expert (Clinical Studies, Market Authorisations, Special Approvals) | Dr. sc. ETH | Bundesamt für Gesundheit, Schweiz, Bern | BAG | Strahlenschutz Sektion Forschung & Nuklearmedizin | Research profile](https://www.researchgate.net/profile/Rolf-Hesselmann/publication/49654817/figure/fig3/AS:394359485812739@1471034036140/year-old-female-patient-34-months-postoperatively-with-no-increased-uptake-around_Q320.jpg)